Confirmatory tau-slowing associations in a single cohort with suspected CTE could reveal mechanistic relationships between tau-induced neurodegeneration and neural slowing, and confirm the latter as a robust surrogate marker for tauopathy. This evidence concerns the gene MAPT and tauopathy.